CD239 promotes the migration of lung carcinoma cells on laminin-511. The over-expression of CD239 is observed in ovarian carcinoma, skin cancer and hepatocellular carcinoma. CD239 is strongly expressed in a subset of breast cancer tissues and cells [38]. This evidence concerns the gene BCAM and skin cancer.